News

Dr Thorsten Boroviak joins us this month (from 1 October) as a Principal Investigator researching primate embryogenesis. Dr Boroviak joins us from the Department of Physiology, Development and Neuroscience at University of Cambridge. CSCI Director Bertie Göttgens comments on Dr Boroviak's appointment:"I am very happy to welcome Thorsten Boroviak to…

Professor Sanjay Sinha and his team have just been announced (28 September) as one of the four world-class teams to receive a share of £18 million to pursue transformational bioscience research programmes.The four teams will tackle bold challenges at the frontiers of bioscience, combining world-class ideas, people and transformative technologies wi…

Neuroblastoma is responsible for 15% of cancer deaths in children. Research out today from the Philpott Lab offers hope to these children, who could in future be given treatments with fewer side-effects than those associated with the current chemotherapy.The approach involves the use of a ‘differentiation therapy’, a type of treatment that does not…

Today (6 September)the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) welcomed Indian entrepreneur Ashok Soota from SKAN Research Trust (SKAN) to Cambridge to mark an upcoming partnership between the two organisations that will bring cutting edge expertise in stem cell research to India. CSCI Director Professor Bertie Göttgens said of the partne…

In March, Cancer Grand Challenges announced nine new challenges, with 178 interdisciplinary, world-class global teams submitting bold ideas to take them on. Today (5 September 2023), 12 teams have been shortlisted to further their research and compete for up to $25m in funding.CSCI PI Maria Alcolea has been announced as one of the Cambridge researc…

Scientists have created a new test for identifying people at risk of developing acute myeloid leukaemia and related cancers, years before they do. The new platform, ‘MN-predict’, will allow doctors and scientists to identify those at risk and to design new treatments to prevent them from developing these potentially lethal cancers. Researchers at t…

Cambridge scientists, in collaboration with colleagues across Europe, have completed the most comprehensive study yet attempted to assess the role of chromatin factors in normal and malignant haematopoiesis, the process of blood formation, in a study published this month in Nature Genetics. The study provides an important breakthrough in explaining…

A study describes organ function crossover in the human yolk sac and presents a new rapid pathway for immune cell differentiation. The role of the human yolk sac in supporting early embryonic development and the first wave of the prenatal immune system has been mapped in a study published yesterday (17 August) in Science. Researchers from the Wellc…

Last week, the Institute held the CSCI Annual Retreat on 5 and 6 June in Cambridge.This event brings together CSCI researchers and Affiliate Group Leaders to share emerging findings, forge collaborations and socialise outside of the office and labs. This year also featured, in addition to the scientific sessions, a special afternoon session that in…

The Royal College of Paediatrics and Child Health (RCPCH) and National Institute of Health Research (NIHR) have awarded their 2023 Paediatric Involvement and Engagement in Research Prize to the research group led by Dr Matthias Zilbauer.The RCPCH-NIHR Paediatric Involvement and Engagement in Research Prize is awarded annually to multidisciplinary r…

Wellcome announced today (4 May) that they will be funding the Cambridge Stem Cell Institute as one of their new Discovery Research Platforms.Discovery Research Platforms will bring together researchers, teams and networks of collaborators to develop new tools, knowledge and capabilities, with the hope of accelerating progress for the benefit of th…

Last night, 24 April 2023, the Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) gather with their new members for an inaugural networking dinner to mark the start of the forum. Initiated with a launch event last November, this forum aims to unite scientists in industry and academia based on a shared interest in stem cells and t…

The Wellcome-MRC Cambridge Stem Cell Institute and the School of Clinical Medicine are pleased to announce that applications are now welcome for the Professorship of Stem Cell Medicine.  We are seeking candidates who have:the vision, leadership experience and enthusiasm to develop and maintain a leading research presence, carrying out original and …

Two CSCI Group Leaders are among the eight researchers from the University of Cambridge who were awarded European Research Council (ERC) Consolidator Grants last week. Dr Elisa Laurenti and Dr Daniel Hodson were selected from over 2,000 applicants for their research conducted at the Wellcome-MRC Cambridge Stem Cell Institute (CSCI). The ERC is the …

Dr Harry Bulstrode joins us this week (1 February) as a Principal Investigator researching neural stem cells in relation to development, regeneration and cancer. Dr Bulstrode joins us most recently from the Francis Crick Institute, where he studied glioma stem cell biology and the tumour microenvironment in malignant gliomas. CSCI Director Bertie G…